Logo image of SSTI

SOUNDTHINKING INC (SSTI) Stock Fundamental Analysis

NASDAQ:SSTI - Nasdaq - US82536T1079 - Common Stock - Currency: USD

11.42  +0.19 (+1.69%)

After market: 11.42 0 (0%)

Fundamental Rating

3

Overall SSTI gets a fundamental rating of 3 out of 10. We evaluated SSTI against 283 industry peers in the Software industry. The financial health of SSTI is average, but there are quite some concerns on its profitability. SSTI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SSTI has reported negative net income.
In the past year SSTI had a positive cash flow from operations.
In multiple years SSTI reported negative net income over the last 5 years.
SSTI had a positive operating cash flow in each of the past 5 years.
SSTI Yearly Net Income VS EBIT VS OCF VS FCFSSTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

The Return On Assets of SSTI (-5.69%) is comparable to the rest of the industry.
SSTI has a Return On Equity of -10.50%. This is comparable to the rest of the industry: SSTI outperforms 51.42% of its industry peers.
Industry RankSector Rank
ROA -5.69%
ROE -10.5%
ROIC N/A
ROA(3y)-1.15%
ROA(5y)-1.55%
ROE(3y)-1.94%
ROE(5y)-3.07%
ROIC(3y)N/A
ROIC(5y)N/A
SSTI Yearly ROA, ROE, ROICSSTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

With a Gross Margin value of 57.14%, SSTI is not doing good in the industry: 62.77% of the companies in the same industry are doing better.
SSTI's Gross Margin has been stable in the last couple of years.
SSTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.81%
GM growth 5Y-0.82%
SSTI Yearly Profit, Operating, Gross MarginsSSTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

4

2. Health

2.1 Basic Checks

SSTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
SSTI has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SSTI has been increased compared to 5 years ago.
SSTI has a better debt/assets ratio than last year.
SSTI Yearly Shares OutstandingSSTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SSTI Yearly Total Debt VS Total AssetsSSTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

SSTI has an Altman-Z score of 0.84. This is a bad value and indicates that SSTI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.84, SSTI is not doing good in the industry: 63.12% of the companies in the same industry are doing better.
SSTI has a debt to FCF ratio of 0.34. This is a very positive value and a sign of high solvency as it would only need 0.34 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.34, SSTI belongs to the best of the industry, outperforming 80.14% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that SSTI is not too dependend on debt financing.
SSTI's Debt to Equity ratio of 0.05 is in line compared to the rest of the industry. SSTI outperforms 57.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.34
Altman-Z 0.84
ROIC/WACCN/A
WACC10.66%
SSTI Yearly LT Debt VS Equity VS FCFSSTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.82 indicates that SSTI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, SSTI is doing worse than 81.21% of the companies in the same industry.
SSTI has a Quick Ratio of 0.82. This is a bad value and indicates that SSTI is not financially healthy enough and could expect problems in meeting its short term obligations.
SSTI has a Quick ratio of 0.82. This is amonst the worse of the industry: SSTI underperforms 80.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
SSTI Yearly Current Assets VS Current LiabilitesSSTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

SSTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -90.63%.
The Revenue has been growing slightly by 7.64% in the past year.
Measured over the past years, SSTI shows a very strong growth in Revenue. The Revenue has been growing by 20.15% on average per year.
EPS 1Y (TTM)-90.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.83%
Revenue 1Y (TTM)7.64%
Revenue growth 3Y20.61%
Revenue growth 5Y20.15%
Sales Q2Q%11.57%

3.2 Future

Based on estimates for the next years, SSTI will show a very strong growth in Earnings Per Share. The EPS will grow by 36.87% on average per year.
The Revenue is expected to grow by 11.96% on average over the next years. This is quite good.
EPS Next Y67.5%
EPS Next 2Y36.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.6%
Revenue Next 2Y7.17%
Revenue Next 3Y12.61%
Revenue Next 5Y11.96%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SSTI Yearly Revenue VS EstimatesSSTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
SSTI Yearly EPS VS EstimatesSSTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SSTI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SSTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SSTI Price Earnings VS Forward Price EarningsSSTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

SSTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SSTI is cheaper than 70.57% of the companies in the same industry.
92.55% of the companies in the same industry are more expensive than SSTI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.16
EV/EBITDA 35.59
SSTI Per share dataSSTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

SSTI's earnings are expected to grow with 36.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.87%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SSTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOUNDTHINKING INC

NASDAQ:SSTI (8/8/2025, 8:07:43 PM)

After market: 11.42 0 (0%)

11.42

+0.19 (+1.69%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners58.02%
Inst Owner Change0.71%
Ins Owners25.02%
Ins Owner Change11.74%
Market Cap144.69M
Analysts80
Price Target23.05 (101.84%)
Short Float %1.27%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3976.47%
Min EPS beat(2)-7943.14%
Max EPS beat(2)-9.81%
EPS beat(4)1
Avg EPS beat(4)-1993.47%
Min EPS beat(4)-7943.14%
Max EPS beat(4)32.5%
EPS beat(8)2
Avg EPS beat(8)-1127.03%
EPS beat(12)3
Avg EPS beat(12)-893.72%
EPS beat(16)3
Avg EPS beat(16)-1172.09%
Revenue beat(2)1
Avg Revenue beat(2)-5.3%
Min Revenue beat(2)-13.87%
Max Revenue beat(2)3.27%
Revenue beat(4)2
Avg Revenue beat(4)-1.83%
Min Revenue beat(4)-13.87%
Max Revenue beat(4)4.23%
Revenue beat(8)2
Avg Revenue beat(8)-1.56%
Revenue beat(12)2
Avg Revenue beat(12)-2.7%
Revenue beat(16)3
Avg Revenue beat(16)-3.35%
PT rev (1m)0%
PT rev (3m)1.19%
EPS NQ rev (1m)-5.53%
EPS NQ rev (3m)-119.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-25.28%
Revenue NQ rev (1m)-0.8%
Revenue NQ rev (3m)-4.94%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.38
P/FCF 12.16
P/OCF 8.46
P/B 1.96
P/tB 19.54
EV/EBITDA 35.59
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.94
FCFY8.22%
OCF(TTM)1.35
OCFY11.82%
SpS8.28
BVpS5.83
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.69%
ROE -10.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.14%
FCFM 11.34%
ROA(3y)-1.15%
ROA(5y)-1.55%
ROE(3y)-1.94%
ROE(5y)-3.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.81%
GM growth 5Y-0.82%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.34
Debt/EBITDA 1.07
Cap/Depr 52.02%
Cap/Sales 4.96%
Interest Coverage N/A
Cash Conversion 458.75%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 0.84
F-Score6
WACC10.66%
ROIC/WACCN/A
Cap/Depr(3y)78.06%
Cap/Depr(5y)84.75%
Cap/Sales(3y)8.57%
Cap/Sales(5y)9.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.83%
EPS Next Y67.5%
EPS Next 2Y36.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.64%
Revenue growth 3Y20.61%
Revenue growth 5Y20.15%
Sales Q2Q%11.57%
Revenue Next Year5.6%
Revenue Next 2Y7.17%
Revenue Next 3Y12.61%
Revenue Next 5Y11.96%
EBIT growth 1Y5.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year729.43%
EBIT Next 3Y144.94%
EBIT Next 5Y99.94%
FCF growth 1Y1467.82%
FCF growth 3Y101.84%
FCF growth 5Y12.45%
OCF growth 1Y76.31%
OCF growth 3Y31.28%
OCF growth 5Y10.17%